"Androstenedione" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A delta-4 C19 steroid that is produced not only in the TESTIS, but also in the OVARY and the ADRENAL CORTEX. Depending on the tissue type, androstenedione can serve as a precursor to TESTOSTERONE as well as ESTRONE and ESTRADIOL.
| Descriptor ID |
D000735
|
| MeSH Number(s) |
D04.210.500.054.079.329 D04.210.500.578.502.112 D06.472.040.502.112 D06.472.334.851.968.875
|
| Concept/Terms |
Androstenedione- Androstenedione
- delta-4-Androstenedione
- delta 4 Androstenedione
- 4-Androstene-3,17-dione
- 4 Androstene 3,17 dione
|
Below are MeSH descriptors whose meaning is more general than "Androstenedione".
Below are MeSH descriptors whose meaning is more specific than "Androstenedione".
This graph shows the total number of publications written about "Androstenedione" by people in this website by year, and whether "Androstenedione" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 1 | 1 |
| 2002 | 1 | 0 | 1 |
| 2003 | 1 | 0 | 1 |
| 2004 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
| 2015 | 1 | 2 | 3 |
| 2017 | 1 | 0 | 1 |
| 2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Androstenedione" by people in Profiles.
-
Impact of age, body weight and metabolic risk factors on steroid reference intervals in men. Eur J Endocrinol. 2020 May; 182(5):459-471.
-
Parallel diurnal fluctuation of testosterone, androstenedione, dehydroepiandrosterone and 17OHprogesterone as assessed in serum and saliva: validation of a novel liquid chromatography-tandem mass spectrometry method for salivary steroid profiling. Clin Chem Lab Med. 2017 Aug 28; 55(9):1315-1323.
-
Anti-m?llerian hormone and insulin-like 3 levels in healthy normal-weight ovulatory and anovulatory eumenorrheic late adolescent females: potential early biomarkers of ovarian dysfunction? Eur J Obstet Gynecol Reprod Biol. 2015 Dec; 195:188-192.
-
Hormonal circadian rhythms in patients with congenital adrenal hyperplasia: identifying optimal monitoring times and novel disease biomarkers. Eur J Endocrinol. 2015 Dec; 173(6):727-37.
-
Dietary Adjuncts for Improving Testosterone Levels in Hypogonadal Males. Am J Mens Health. 2016 11; 10(6):NP109-NP117.
-
AR collaborates with ERa in aromatase inhibitor-resistant breast cancer. Breast Cancer Res Treat. 2014 Oct; 147(3):473-85.
-
Luteinizing hormone/human chorionic gonadotropin-mediated activation of mTORC1 signaling is required for androgen synthesis by theca-interstitial cells. Mol Endocrinol. 2012 Oct; 26(10):1732-42.
-
Regulation of sterol regulatory element-binding transcription factor 1a by human chorionic gonadotropin and insulin in cultured rat theca-interstitial cells. Biol Reprod. 2009 Aug; 81(2):284-92.
-
Newborn screening for congenital adrenal hyperplasia: additional steroid profile using liquid chromatography-tandem mass spectrometry. J Clin Endocrinol Metab. 2007 Jul; 92(7):2581-9.
-
Glucose intolerance in a large cohort of mediterranean women with polycystic ovary syndrome: phenotype and associated factors. Diabetes. 2004 Sep; 53(9):2353-8.